Zebra Medical Receives the US FDA’s Approval for its HealthMammo Mammography Tool

 Zebra Medical Receives the US FDA’s Approval for its HealthMammo Mammography Tool

Shots:

  • The US FDA has granted 510 (k) clearance to HealthMammo for boosting early detection of breast cancer in mammograms
  • The tool utilizes the AI to prioritize and identify suspicious mammograms and is automatically sent to Zebra’s platform, where it gets processed and analyzed for suspected breast lesions. The HealthMammo product then returns its result to the radiologist
  • Zebra Medical’s HealthMammo may help radiologists deal with the screening management strategy of the post COVID backlog and triaging. The tool is the first solution for oncology to receive FDA clearance, as part of the company’s AI1 “All-In-One” bundle

Click here ­to­ read full press release/ article | Ref: Business wire | Image: Business wire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post